{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,25]],"date-time":"2026-03-25T11:23:34Z","timestamp":1774437814095,"version":"3.50.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T00:00:00Z","timestamp":1410912000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Neurovirol."],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1007\/s13365-014-0289-8","type":"journal-article","created":{"date-parts":[[2014,9,17]],"date-time":"2014-09-17T17:34:53Z","timestamp":1410975293000},"page":"632-636","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Progressive multifocal leukoencephalopathy therapy"],"prefix":"10.1007","volume":"21","author":[{"given":"David B.","family":"Clifford","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,9,17]]},"reference":[{"key":"289_CR1","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1212\/WNL.0b013e3182768983","volume":"79","author":"C Antoniol","year":"2012","unstructured":"Antoniol C, Jilek S, Schluep M et al (2012) Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management? Neurology 79:2258\u20132264","journal-title":"Neurology"},{"key":"289_CR2","doi-asserted-by":"crossref","first-page":"13490","DOI":"10.1128\/JVI.02252-13","volume":"87","author":"B Assetta","year":"2013","unstructured":"Assetta B, Maginnis MS, Gracia Ahufinger I et al (2013) 5-HT2 receptors facilitate JC polyomavirus entry. J Virol 87:13490\u201313498","journal-title":"J Virol"},{"key":"289_CR3","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1002\/ana.410440309","volume":"44","author":"JR Berger","year":"1998","unstructured":"Berger JR, Levy RM, Flomenhoft D, Dobbs M (1998) Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 44:341\u2013349","journal-title":"Ann Neurol"},{"key":"289_CR4","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJMoa1107829","volume":"366","author":"G Bloomgren","year":"2012","unstructured":"Bloomgren G, Richman S, Hotermans C et al (2012) Risk of natalizumab-associated progressive multifocal leukoencephalopathy. N Engl J Med 366:1870\u20131880","journal-title":"N Engl J Med"},{"key":"289_CR5","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1128\/AAC.01614-08","volume":"53","author":"M Brickelmaier","year":"2009","unstructured":"Brickelmaier M, Lugovskoy A, Kartikeyan R et al (2009) Identification and characterization of mefloquine efficacy against JC virus in vitro. Antimicrob Agents Chemother 53:1840\u20131849","journal-title":"Antimicrob Agents Chemother"},{"key":"289_CR6","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1080\/13550280152537247","volume":"7","author":"P Cinque","year":"2001","unstructured":"Cinque P, Pierotti C, Vigano MG et al (2001) The good and evil of HAART in HIV-related progressive multifocal leukoencephalopathy. J Neurovirol 7:358\u2013363","journal-title":"J Neurovirol"},{"key":"289_CR7","first-page":"A249","volume":"50","author":"DB Clifford","year":"1998","unstructured":"Clifford DB, Team NARCS (1998) Impact on highly active antiretroviral therapy on survival from progressive multifocal leukoencephalopathy in human immunodeficiency virus infection. Neurology 50:A249","journal-title":"Neurology"},{"key":"289_CR8","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S1474-4422(10)70028-4","volume":"9","author":"DB Clifford","year":"2010","unstructured":"Clifford DB, DeLuca A, Simpson DM, Arendt G, Giovannoni G, Nath A (2010) Natalizumab-associated progressive multifocal leukoencephalopathy in patients with multiple sclerosis: lessons from 28 cases. Lancet Neurol 9:438\u2013446","journal-title":"Lancet Neurol"},{"key":"289_CR9","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1001\/archneurol.2011.103","volume":"68","author":"DB Clifford","year":"2011","unstructured":"Clifford DB, Ances B, Costello C et al (2011) Rituximab-associated progressive multifocal leukoencephalopathy in rheumatoid arthritis. Arch Neurol 68:1156\u20131164","journal-title":"Arch Neurol"},{"key":"289_CR10","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s13365-013-0173-y","volume":"19","author":"DB Clifford","year":"2013","unstructured":"Clifford DB, Nath A, Cinque P et al (2013) A study of mefloquine treatment for progressive multifocal leukoencephalopathy: results and exploration of predictors of PML outcomes. J Neurovirol 19:351\u2013358","journal-title":"J Neurovirol"},{"key":"289_CR11","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1097\/QAD.0b013e32830a5043","volume":"22","author":"A Luca De","year":"2008","unstructured":"De Luca A, Ammassari A, Pezzotti P et al (2008) Cidofovir in addition to antiretroviral treatment is not effective for AIDS-associated progressive multifocal leukoencephalopathy: a multicohort analysis. AIDS 22:1759\u20131767","journal-title":"AIDS"},{"key":"289_CR12","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1126\/science.1103492","volume":"306","author":"GF Elphick","year":"2004","unstructured":"Elphick GF, Querbes W, Jordan JA et al (2004) The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 306:1380\u20131383","journal-title":"Science"},{"key":"289_CR13","first-page":"1005","volume":"9","author":"J Gadzia","year":"2010","unstructured":"Gadzia J, Turner J (2010) Progressive multifocal leukoencephalopathy in two psoriasis patients treated with efalizumab. J Drugs Dermatol 9:1005\u20131009","journal-title":"J Drugs Dermatol"},{"key":"289_CR14","doi-asserted-by":"crossref","first-page":"e20967","DOI":"10.1371\/journal.pone.0020967","volume":"6","author":"J Gasnault","year":"2011","unstructured":"Gasnault J, Costagliola D, Hendel-Chavez H et al (2011) Improved survival of HIV-1-infected patients with progressive multifocal leukoencephalopathy receiving early 5-drug combination antiretroviral therapy. PLoS One 6:e20967","journal-title":"PLoS One"},{"key":"289_CR15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1080\/13550280152537238","volume":"7","author":"MD Geschwind","year":"2001","unstructured":"Geschwind MD, Skolasky RI, Royal WS, McArthur JC (2001) The relative contributions of HAART and alpha-interferon for therapy of progressive multifocal leukoencephalopathy in AIDS. JNeurovirol 7:353\u2013357","journal-title":"JNeurovirol"},{"key":"289_CR16","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1056\/NEJMc1304828","volume":"370","author":"PS Giacomini","year":"2014","unstructured":"Giacomini PS, Rozenberg A, Metz I et al (2014) Maraviroc and JC virus-associated immune reconstitution inflammatory syndrome. N Engl J Med 370:486\u2013488","journal-title":"N Engl J Med"},{"key":"289_CR17","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.4049\/jimmunol.172.7.4018","volume":"172","author":"WG Glass","year":"2004","unstructured":"Glass WG, Hickey MJ, Hardison JL, Liu MT, Manning JE, Lane TE (2004) Antibody targeting of the CC chemokine ligand 5 results in diminished leukocyte infiltration into the central nervous system and reduced neurologic disease in a viral model of multiple sclerosis. J Immunol 172:4018\u20134025","journal-title":"J Immunol"},{"issue":"Suppl 3","key":"289_CR18","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1080\/13550280500511741","volume":"11","author":"F Gray","year":"2005","unstructured":"Gray F, Bazille C, Adle-Biassette H, Mikol J, Moulignier A, Scaravilli F (2005) Central nervous system immune reconstitution disease in acquired immunodeficiency syndrome patients receiving highly active antiretroviral treatment. J Neurovirol 11(Suppl 3):16\u201322","journal-title":"J Neurovirol"},{"key":"289_CR19","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJM199805073381903","volume":"338","author":"CD Hall","year":"1998","unstructured":"Hall CD, Dafni U, Simpson D et al (1998) Failure of cytarabine in progressive multifocal leukoencephalopathy associated with human immunodeficiency virus infection. N Engl J Med 338:1345\u20131351","journal-title":"N Engl J Med"},{"key":"289_CR20","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/13550289809114545","volume":"4","author":"J Hou","year":"1998","unstructured":"Hou J, Major EO (1998) The efficacy of nucleoside analogs against JC virus multiplication in a persistently infected human fetal brain cell line. J Neurovirol 4:451\u2013456","journal-title":"J Neurovirol"},{"key":"289_CR21","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1002\/ana.21085","volume":"62","author":"D Huang","year":"2007","unstructured":"Huang D, Cossoy M, Li M et al (2007) Inflammatory progressive multifocal leukoencephalopathy in human immunodeficiency virus-negative patients. Ann Neurol 62:34\u201339","journal-title":"Ann Neurol"},{"key":"289_CR22","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S1474-4422(11)70149-1","volume":"10","author":"L Kappos","year":"2011","unstructured":"Kappos L, Bates D, Edan G et al (2011) Natalizumab treatment for multiple sclerosis: updated recommendations for patient selection and monitoring. Lancet Neurol 10:745\u2013758","journal-title":"Lancet Neurol"},{"key":"289_CR23","first-page":"S172","volume":"13","author":"B Khatri","year":"2007","unstructured":"Khatri B, Fox R, Koo A et al (2007) The effect of plasma exchange in accelerating clearance of natalizumab in patients with multiple sclerosis: results of the PLEX study (poster presented at 23rd Congress of the European Committee for Treatment and Research in Multiple Sclerosis - ECTRIMS). Mult Scler 13:S172","journal-title":"Mult Scler"},{"key":"289_CR24","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1212\/01.wnl.0000183064.10227.b5","volume":"65","author":"L Kunschner","year":"2005","unstructured":"Kunschner L, Scott TF (2005) Sustained recovery of progressive multifocal leukoencephalopathy after treatment with IL-2. Neurology 65:1510","journal-title":"Neurology"},{"key":"289_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00002030-200209060-00012","volume":"16","author":"CM Marra","year":"2002","unstructured":"Marra CM, Rajicic N, Barker DE et al (2002) A pilot study of cidofovir for progressive multifocal leukoencephalopathy in AIDS. AIDS 16:1\u20137","journal-title":"AIDS"},{"key":"289_CR26","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1097\/QAD.0b013e32833365f4","volume":"23","author":"G Martin-Blondel","year":"2009","unstructured":"Martin-Blondel G, Cuzin L, Delobel P et al (2009) Is maraviroc beneficial in paradoxical progressive multifocal leukoencephalopathy-immune reconstitution inflammatory syndrome management? AIDS 23:2545\u20132546","journal-title":"AIDS"},{"key":"289_CR27","doi-asserted-by":"crossref","first-page":"2697","DOI":"10.1093\/jac\/dkq359","volume":"65","author":"A Patel","year":"2010","unstructured":"Patel A, Patel J, Ikwuagwu J (2010) A case of progressive multifocal leukoencephalopathy and idiopathic CD4+ lymphocytopenia. J Antimicrob Chemother 65:2697\u20132698","journal-title":"J Antimicrob Chemother"},{"key":"289_CR28","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1056\/NEJMoa1201248","volume":"367","author":"R Reshef","year":"2012","unstructured":"Reshef R, Luger SM, Hexner EO et al (2012) Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease. N Engl J Med 367:135\u2013145","journal-title":"N Engl J Med"},{"key":"289_CR29","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1212\/01.wnl.0000343510.08643.74","volume":"72","author":"K Tan","year":"2009","unstructured":"Tan K, Roda R, Ostrow L, McArthur J, Nath A (2009) PML-IRIS in patients with HIV infection. Clinical manifestations and treatment with steroids. Neurology 72:1458\u20131464","journal-title":"Neurology"},{"key":"289_CR30","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1212\/WNL.0b013e31822e55e7","volume":"77","author":"IL Tan","year":"2011","unstructured":"Tan IL, McArthur JC, Clifford DB, Major EO, Nath A (2011) Immune reconstitution inflammatory syndrome in natalizumab-associated PML. Neurology 77:1061\u20131067","journal-title":"Neurology"},{"key":"289_CR31","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJMoa054693","volume":"354","author":"TA Yousry","year":"2006","unstructured":"Yousry TA, Major EO, Ryschkewitsch C et al (2006) Evaluation of patients treated with natalizumab for progressive multifocal leukoencephalopathy. N Engl J Med 354:924\u2013933","journal-title":"N Engl J Med"}],"container-title":["Journal of NeuroVirology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-014-0289-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s13365-014-0289-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s13365-014-0289-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,2]],"date-time":"2019-06-02T16:08:32Z","timestamp":1559491712000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s13365-014-0289-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,9,17]]},"references-count":31,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["289"],"URL":"https:\/\/doi.org\/10.1007\/s13365-014-0289-8","relation":{},"ISSN":["1355-0284","1538-2443"],"issn-type":[{"value":"1355-0284","type":"print"},{"value":"1538-2443","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,9,17]]}}}